Noel Wardle writes for P3 Pharmacy on the risks of using volunteers to deliver medicines
Noel Wardle has written for P3 Pharmacy on the risks of using volunteers to deliver medicines. Read more below.
What are the risks of using volunteers to deliver medicines?
Our thinking
Sara Wilson
Sleep-in workers not entitled to NMW for entire shift
A unanimous ruling by The Supreme Court in the Royal Mencap v Tomlinson-Blake and another case.
Amelia Goodwin
Amelia Goodwin quoted by People Management, Home Care Insight and Care Home Management on the implications of the Supreme Court's ruling in Royal Mencap Society v Tomlinson-Blake
The court found that care providers do not have to pay the minimum wage to staff for time that they are asleep but on call during shifts.
Noel Wardle
Pharmacy Brief - March 2021
The March edition of our Pharmacy Brief
Jonathan Steele
The firm's role in advising Dentex on the acquisition of The Essex Smile Centre reported by Business Money
The sale of The Essex Smile Centre to Dentex Healthcare Group Limited has been completed.
Natalie Deuchar
Natalie Deuchar and Leonora Owens write for Pharmacy Business on the considerations to take into account when pharmacists look to obtain a new unit
Pharmacists should be aware of the law when considering obtaining a new unit.
Noel Wardle
Noel Wardle quoted by Chemist and Druggist on the issues that need to be considered before pharmacies adopt a hub-and-spoke dispensing model
Under current legislation, the hub-and-spoke model can be carried out by pharmacies owned by the same legal entity.
Noel Wardle
Noel Wardle writes for Chemist and Druggist on whether pharmacy professionals can be sued for COVID vaccine negligence
Rebecca Burford
Charles Russell Speechlys' Corporate team shortlisted for the 2021 South East Dealmakers Awards
Our Guildford team shortlisted at the Insider South East Dealmakers Awards 2021 for Corporate Law Firm of the Year.
Noel Wardle
Pharmacy Brief - December 2020
The December edition of our Pharmacy Brief
William Nash
Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines .
Mark Howard
Public Company Update - November 2020
The November 2020 edition of our biannual Public Company Update.
Noel Wardle
Noel Wardle writes for Chemist and Druggist on how pharmacists can supply the COVID-19 vaccine lawfully
Caroline Greenwell
Safeguarding search orders and the role of public interest: lessons to be learned from recent case law
Caroline looks at lessons to be learned from the recent decision in Calor Gas Ltd v Chorley Bottle Gas Ltd and others
Helen Wong
Charles Russell Speechlys advises on sale of dental practice Feltham Dental
Feltham Dental was established in 1982, the business is an integral part of the community and has many generations of loyal patients.
Pei-Li Kew writes for P3 Pharmacy on the differences between share and asset transactions when buying a pharmacy
Noel Wardle writes for Pharmacy Business on whether a notice to close a pharmacy can be withdrawn
Michael Lingens
Charles Russell Speechlys advises CareTech on the acquisition of Smartbox
Smartbox is a market-leading creator of software and hardware that helps disabled people without speech to live more independently.
Hamish Perry
Charles Russell Speechlys advises Wimbledon NeuroCare and Ascot Rehabilitation on the acquisition of a healthcare diagnostic centre
Both Ascot Rehab and Wimbledon NeuroCare provide high quality rehabilitation services for people with neurological conditions.
Noel Wardle writes for Chemist & Druggist on the downsides of the new MUR legislation
Ayman Shehata
High Stakes
On 18 September, the FCA set out its approach in assessing applications by cannabis-related companies for listing in the UK.